SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention as investors position for potential SpaceX and Anthropic liquidity events, with many viewing the fund as a concentrated proxy for these high-growth private tech assets. Market participants are actively comparing its valuation and portfolio density against other vehicles like VCX, debating whether the current price offers a strategic entry point relative to the fund's underlying net asset value.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing heightened volatility and intense community debate as investors navigate a complex landscape of legal challenges, including trademark disputes with the NCAA and regulatory uncertainty surrounding the rise of prediction markets. While some investors view the recent price drop as a strategic buying opportunity driven by sentiment rather than fundamentals, others are aggressively shorting the stock, citing concerns over insider selling and a shifting competitive environment.

BioLLM

BioLLM is currently circulating across social platforms through aggressive promotional campaigns that frequently associate the token with major tech and financial assets. While some market participants are actively pushing for rapid price appreciation, others are voicing skepticism and labeling the asset as a speculative pump-and-dump scheme.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as investors digest a series of mixed financial performance signals and technical challenges that have frustrated the retail trading community. While the firm reports record client asset growth and robust engagement, users are actively venting about platform instability, restrictive trading policies on volatile stocks, and the ongoing integration pains following the TD Ameritrade acquisition.

Polywhale

The community is buzzing around KRILL as investors debate its potential for rapid growth and compare it against other whale-themed tokens. Discussions highlight ease of entry, speculative sentiment, and confusion over exchange availability as participants navigate volatility.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a focal point for investors, driven by community enthusiasm for staking opportunities and its evolving role in institutional finance as a digital commodity. While some traders monitor price consolidation and market volatility, others remain bullish on its long-term utility, actively discussing accumulation strategies amidst broader macroeconomic uncertainty.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing extreme volatility and intense community speculation, driven by its high-purity exposure to high-profile private tech unicorns like SpaceX and Anthropic. Investors are actively debating whether the stock's massive premium over its net asset value represents a sustainable meme-driven breakout or an inevitable collapse as traders monitor limited share float and lock-up restrictions.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is facing a sharp sell-off despite delivering a double beat on earnings and revenue, as investors react negatively to licensing revenue falling short of high expectations and a broader market trend of rotating out of premium-priced tech. While community sentiment remains split between long-term believers in the company's AI-driven royalty growth and bears criticizing the high valuation multiples, the stock is experiencing significant volatility as it reconciles its strong guidance with a skeptical market backdrop.

ORCASM is a filthy little memecoin that knows exactly what you came for. It launched on Orca's Wavebreak but was born to make waves—wet, loud, and unforgettable. This isn’t your ordinary meme. ORCASM builds up the tension slow, goes deep, and leaves you gasping for more. It’s raw, unfiltered trencher energy dripping with shameless satisfaction. No promises. No roadmaps. Just pure, orcasmic pleasure.

Orcasm

The ORCASM cryptocurrency is gaining significant momentum on social media as investors treat it as the latest high-risk, high-reward meme play following in the footsteps of similar marine-themed tokens. The community is actively debating the coin's potential to drop zeros and hit higher valuations while navigating intense skepticism and accusations of it being a pump-and-dump scheme.

FUST (Fusion token) is the companion token of FUSD - with tokenomics which mirror those of a typical cryptocurrency. FUST can be placed in the FUST Fusion Miner and used to mine free FUSD. FUST has tokenomics which mirror those of a typical cryptocurrency, and allows those Degens who buy into the FUSD philosophy - but who also enjoy the thrill of chasing fast green candles - to make their play within the structure of the FUSD ecosystem and benefit from the best of both worlds; the possibility of a fast ride upwards whilst earning a passive income paid in our appreciating stable token courtesy of their FUST bag.

FUST Token

FUST is gaining momentum as investors highlight its unique ecosystem designed to generate passive income through an appreciating stablecoin model. The community is actively discussing upcoming project milestones, including NFT launcher integrations and a significant distribution initiative, as they view the token as a utility-focused alternative to traditional stagnant stablecoins.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Forecasts InflaRx's Q3 Earnings (NASDAQ:IFRX)

InflaRx N.V. (NASDAQ:IFRX - Free Report) - Analysts at HC Wainwright issued their Q3 2026 EPS estimates for InflaRx in a research note issued on Thursday, March 19th. HC Wainwright analyst M. Keller...

InflaRx (NASDAQ:IFRX) Given New $14.00 Price Target at Guggenheim

Guggenheim cut their target price on InflaRx from $22.00 to $14.00 and set a "buy" rating on the stock in a research note on Friday...

Q1 Earnings Forecast for InflaRx Issued By HC Wainwright

InflaRx N.V. (NASDAQ:IFRX - Free Report) - Investment analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for InflaRx in a research note issued on Thursday, March 19th. HC Wainwright analyst M. Keller anticipates that the company will post earnings of ($0.14) per share...

InflaRx (NASDAQ:IFRX) Issues Earnings Results, Misses Expectations By $0.03 EPS

InflaRx (NASDAQ:IFRX - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.20) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by...

InflaRx N.V. (IFRX) Reports Q4 Loss, Lags Revenue Estimates

InflaRx (IFRX) delivered earnings and revenue surprises of +2.86% and -117.03%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

InflaRx (IFRX) to Release Earnings on Thursday

InflaRx (NASDAQ:IFRX) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 19. (View Earnings Report at...

InflaRx Showcases Izicopan HS and CSU Data, Streamlines C5aR Strategy at Oppenheimer Conference

InflaRx (NASDAQ:IFRX) highlighted recent clinical updates and strategic priorities for its complement inhibition platform during a presentation at Oppenheimer's 36th Annual Healthcare Life Sciences...

InflaRx Spotlights Izicopan HS Data, Phase 2b Plans and 30% Cost Cuts at Guggenheim Summit

InflaRx (NASDAQ:IFRX) highlighted progress on its oral C5a receptor 1 (C5aR) antagonist izicopan and outlined upcoming development plans during a presentation at the Guggenheim Outlook Biotech Summit...

InflaRx N.V. (NASDAQ:IFRX) Given Consensus Recommendation of "Moderate Buy" by Analysts

InflaRx N.V. (NASDAQ:IFRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven brokerages that are presently covering the company, MarketBeat.com reports. One research...

InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of InflaRx N.V. (NASDAQ:IFRX - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight brokerages that are currently covering the stock, MarketBeat reports. One...

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

IFRX
InflaRx N.V.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IFRX News

IFRXInflaRx N.V.